WSJ What's News

The Wall Street Journal

Business, Business News, News & Politics

Chart Positions

Business News 2
Business 20

Top stories. Timely insights. From business and markets to politics and breaking news, stay informed on the news you need to know throughout your day with WSJ journalists and notable influencers.


Why Valeant Is Causing Mutual Fund Headaches

March 23rd, 2016

Episode 365 of 1510 episodes

Dozens of companies have the Sequoia mutual fund as an investment option in their employee savings plans. But Sarah Krouse of the Wall Street Journal says Sequoia's biggest holding is Valeant Pharmaceuticals; the drugmaker's stock has fallen 70 percent this year over questions about its accounting and business practices.

Featured Podcast